全基因组NIPT检出罕见常染色体三体的表现、结局及理论嵌合比探索
单中心回顾性队列纳入64,889例单胎妊娠接受全基因组无创产前检测,112例(0.17%)罕见常染色体三体阳性,其中79例侵入性诊断胎儿确诊阳性预测值5.1%,含UPD/ROH时诊断率8.9%。随访104例中34例不良妊娠结局,理论嵌合比区分不良结局能力差(AUC 0.643),≥0.63校正后与不良结局相关(aOR 3.66)。
要点
- RATs阳性NIPT胎儿确诊率低(PPV 5.1%),但不良妊娠结局风险临床意义明确。
- 理论嵌合比TMR≥0.63校正后与不良结局相关(aOR 3.66,95%CI 1.33-10.05;p=0.012)。
- TMR单独区分不良结局能力差(AUC 0.643),需结合染色体、诊断、超声及产科情况解读。
核心结论
- RATs阳性NIPT结果虽胎儿确诊率低,仍携带临床意义的妊娠风险。
- TMR在不良妊娠结局中更高,但重叠与ROC表现差限制其单独使用,应作为补充指标结合其他临床信息解读。
研究设计与样本
- 单中心回顾性队列研究,纳入64,889例单胎妊娠(2021年3月至2024年7月)接受全基因组无创产前检测。
- RATs阳性病例通过侵入性诊断、妊娠结局及序列衍生标志物(含平台特异性理论嵌合比TMR)评估。
主要发现
- 112例RATs阳性(0.17%),79例接受侵入性诊断,胎儿确诊阳性预测值5.1%(4/79)。
- 含UPD/ROH发现时诊断率8.9%(7/79)。
- 随访104例中63例无并发症妊娠、34例不良妊娠结局、7例终止妊娠。
- 93例主要分析中TMR对不良结局区分能力差(AUC 0.643,95%CI 0.531-0.756)。
- 校正后TMR≥0.63与不良结局相关(校正OR 3.66,95%CI 1.33-10.05;p=0.012)。
临床怎么用
- RATs阳性NIPT应进行侵入性诊断确认,并评估UPD/ROH。
- TMR不宜单独用于预测不良结局,需结合染色体、诊断、超声及产科发现综合解读。
局限性
- 单中心回顾性设计。
- TMR对不良结局区分能力差(AUC 0.643),存在重叠。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize rare autosomal trisomies (RATs) detected by genome-wide noninvasive prenatal testing (GW-NIPT), evaluate their clinical significance, and explore whether sequencing-derived parameters are associated with adverse pregnancy outcomes. METHODS: This single-center retrospective cohort study included 64,889 singleton pregnancies undergoing GW-NIPT (March 2021-July 2024). RATs-positive cases were evaluated using invasive diagnostics, pregnancy outcomes, and sequence-derived markers, including a platform-specific theoretical mosaicism ratio (TMR). RESULTS: Of 112 RATs-positive pregnancies (0.17%), 79 underwent invasive diagnosis. Positive predictive value (PPV) for fetal confirmation was 5.1% (4/79) and diagnostic yield was 8.9% (7/79) when uniparental disomy/runs of homozygosity (UPD/ROH) findings were included. Follow-up of 104 pregnancies included 63 uncomplicated pregnancies, 34 adverse pregnancy outcomes, and 7 terminations of pregnancy (TOP). In the primary analysis of 93 pregnancies, the TMR showed poor discrimination for adverse outcomes (AUC 0.643, 95% CI 0.531-0.756). TMR ≥ 0.63 was associated with adverse outcomes after adjustment (adjusted OR 3.66, 95% CI 1.33-10.05; p = 0.012). CONCLUSIONS: RATs-positive NIPT results carried clinically meaningful pregnancy risk despite low fetal confirmation rates. TMR was higher with adverse pregnancy outcomes, but overlap and poor receiver operating characteristic (ROC) performance limit standalone use. TMR should be supplementary, interpreted in the context of chromosome, diagnostic, ultrasound, and obstetric findings.
引用
- Liu Y, Wang J, Wang G, et al. Rare Autosomal Trisomies Detected by Noninvasive Prenatal Testing: Performance, Outcomes, and Exploratory Analysis of the Theoretical Mosaicism Ratio. Prenat Diagn. 2026. PMID: 42631554. doi:10.1002/pd.70237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。